gemcitabine,cisplatin,carboplatin,enfortumab,pembrolizumab
astellas,seagen,merck
['cisplatin', 'enfortumab', 'vedo', 'ev103', 'mibc', ' vedo']
#ev103: neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients with #mibc: updated results for cohort h. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology